- Key Information
- Timeline
- How to Prepare
- Training and Learning the New System
- What to Expect at Go-Live
- OnCore Integration
- Frequently Asked Questions
- Contact
- Information Sessions
- Previous Communications
UCSF is replacing the iRIS IRB submission system with a new system called Research Gateway IRB. This page explains why the change is happening, key transition dates, how to prepare, and what to expect during the transition.
This page will be continually updated with additional guidance—especially the FAQs—so please revisit often!
Research Gateway IRB Transition
📤
Wed, April 1
Submit in iRIS by 4/1 for best chance of approval before go live.
Key Information
| Change | Impact/Details |
|---|---|
| What is changing? |
|
| Who is affected: |
|
| Key transition dates: |
|
Timeline
| Milestone | Description | Date |
|---|---|---|
| Submission Freeze | No IRB submissions accepted during migration preparation | June 13 - June 30, 2026 |
| Research Gateway IRB Go-Live | New system opens for submissions | Wed, July 1, 2026 |
| iRIS Sunset | Read-only access expected to end - archived data from iRIS will be accessible in another system. | Mid-2027 (tentative) |
Submission Freeze, June 13-30th, 2026
No submissions will be accepted in iRIS or Research Gateway IRB starting at 12:00AM on June 13, 2026. This includes:
- New studies, Modifications & Personnel Changes, Continuing Reviews, Reportable New Information (Adverse Events, Protocol Violations, Incidents, and other reportable information), and Adding Relying Sites
How to Prepare
| Category | Key Actions & Requirements |
|---|---|
| Manage Approved iRIS Studies | ❌ Remove research personnel who are no longer part of the study according to IRB guidance on personnel changes. Some approved iRIS studies may fail to migrate to Research Gateway IRB if they include Key Study Personnel (KSP) who are no longer affiliated with UCSF. See the IRB quick guide for step-by-step instructions on updating study personnel.
|
| Manage Submissions Undergoing IRB Review | To increase the likelihood of IRB approval before the system transition, please:
Note: Submissions not approved before the transition must be resubmitted in Research Gateway IRB. |
Consider Timing for Upcoming Submissions
| Submission Type | Guidance/Next Steps |
|---|---|
| Any submission that does not fit into one of the below categories | If possible, wait until after Wed, July 1, 2026.If your submission does not require approval before the transition, consider delaying it until the new system launches. This includes:
Tip: Submissions made after July 1, 2026, may help avoid the need to recreate submissions in the new system. If approval is needed before the transition:If your study requires approval before the system change, submit as early as possible. Please note:
|
| New Full Committee Studies | New studies that require Full Committee Review are no longer being accepted in iRIS. Submit new Full Committee Studies in Research Gateway IRB beginning Wed, July 1, 2026. Training and materials will be available in June to get you ready for a July 1st submission. |
| Continuing Review | 🔄 Use this chart to determine when and how to submit your Continuing Review: IRB Continuing Review Schedule April-September 2026. |
| Reportable New Information: Adverse events, protocol violations & incidents, and reportable safety information | 🛑 Do not submit reportable new information during the submission freeze unless it may affect whether the study can continue. In such cases, notify us via the Ask Andy form. If the event does not impact study continuation, wait to submit it in Research Gateway IRB. |
| Reliance | If you plan to add external sites: 🤝 Request a Reliance team consultation early, as the process will change with the new system. If you wish to rely on an external academic medical center IRB, or any IRB other than WCG, Advarra, Jaeb, NCI CIRB, or Fresno Community Health System (formerly Community Medical Centers in Fresno):
Studies relying on WCG, Advarra, Jaeb, NCI CIRB, or Fresno Community Health System (formerly Community Medical Centers in Fresno) will follow the standard submission freeze timeframe. |
Training and Learning the New System
Training schedules and materials are available on the Research Gateway IRB training page.
What to Expect at Go-Live
What should you do after Wed, July 1, 2026?
Your next steps depend on your study's status in iRIS. Choose your situation:
| If this applies to you | Go to section |
|---|---|
| My study was already approved in IRIS | Approved studies |
| My submission was under review in iRIS but not approved before July 1, 2026 | Resubmitting after the transition |
| I am submitting a new study, modification, personnel change, continuing review, or reportable new information after July 1, 2026. | New submissions after go-live |
📣 Three Big Changes to Expect in Research Gateway IRB
| Change | Detailed Guidance | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study SmartForm + Investigator Protocol | The current IRB Application in iRIS is a highly programmed SmartForm that uses show/hide logic. In the new Research Gateway IRB system, we are moving to a more document-driven approach. You will still complete an IRB Study SmartForm, but it will be significantly shorter. Most study information will instead be captured in a Word document called the Investigator Protocol, which you will complete using a template and upload in the SmartForm. This approach makes it easier for study teams to collaborate and allows you to view all IRB questions at once, rather than navigating through them step by step. Detailed mapping documents will be available to show how current iRIS questions align with the new Investigator Protocol template. Templates will be shared in June. Note: While some questions have been reworded or combined, most will feel familiar. And you’ll be pleased to hear that several questions have been removed entirely. Approved studies being migrated will receive a partially pre-populated Investigator Protocol based on information from their most recent iRIS application.
| |||||||||||||||
| Separate Submission to GESCR via the Safety Module | Another change involves the Human Gamete, Embryo, and Stem Cell Research (GESCR) submission process. In iRIS, the GESCR application is embedded within the IRB application. However, not all GESCR studies require IRB review, which means some study teams currently answer IRB questions that do not apply to their research. In the Research Gateway IRB system, GESCR and IRB submissions will be separated. GESCR studies will be submitted through the Safety Module and can be linked to a corresponding IRB submission when review by both groups is required. | |||||||||||||||
| System Roles and Notification Recipients | Some system roles and notification recipients are changing in the Research Gateway IRB system. The PI Proxy RoleThe PI Proxy is a new system role that allows a designated individual to submit an IRB submission on behalf of the PI. Key details regarding this role include:
The Primary Contact RoleThe Primary Contact is another system role in Research Gateway IRB. Unlike iRIS, where multiple Study Contacts can receive notifications, Research Gateway IRB allows only one Primary Contact per study. This individual will be copied on all system notifications. Here’s a table summarizing these changes:
|
🔁 What information will be migrated from iRIS to Research Gateway?
Not all information will move to the new system. Review the lists below to understand what will be transferred and what may require your attention.
- What will migrate?
- What will not migrate?
- Migration Summary Table (IRB and GESCR Submissions & Documents)
| What will migrate? | Guidance |
|---|---|
| Approved IRB Studies | Most currently approved studies will have a “shell record” created in Research Gateway IRB. This means information from your iRIS study record will be migrated to pre-populate most – but not all – of the new Study SmartForm in Research Gateway IRB. When you submit your first modification in Research Gateway IRB, you will need to review and validate this information, complete any missing fields, and upload a completed UCSF Investigator Protocol. Please see Key System Changes. Studies with the following statuses at the time of the submission freeze will be migrated:
|
| Post-approval event reports (limited) | Only reports with any of the following outcomes will be migrated:
Note: In Research Gateway IRB, these are called Reportable New Information (RNI). |
| Basic regulatory information | Limited regulatory data needed to support ongoing IRB oversight will be migrated, such as expiration dates (if applicable) and select approval information. |
| Current approved/acknowledged consent forms and other study documents | Documents that are approved/acknowledged at the time of the submission freeze will be migrated (see migration table) |
| Approved GESCR studies | In Research Gateway, GESCR submissions will be separate from IRB submissions and will be managed within the Safety Module. Depending on whether your study involves human research, it will be migrated to both the IRB and Safety modules, or to Safety only. A “shell record” will be created for each GESCR study in the Safety Module. Because only limited GESCR information can be migrated, you will need to review and validate the migrated data and complete any missing fields when prompted. |
| What will not migrate? | Guidance |
|---|---|
| This information will be accessible in iRIS until it is taken offline in 2027. Most information will also be accessible in SharePoint via a link in Research Gateway IRB (exceptions noted). | |
| Exempt studies | Your non-closed, exempt study is still considered “active” even though it has not been migrated to the Research Gateway IRB. You can continue to conduct the research. If you need to make changes to the study, first consider whether the changes are minor or significant.
|
| Closed or withdrawn studies | |
| Previously approved modifications and continuing reviews | |
| Currently unapproved consent forms and other study documents | Includes drafts or prior versions of consent forms and other study documents that are not currently approved at the time of the submission freeze. |
| Most post-approval event reports. | See exceptions in the list above. |
| IRB outcome letters | Includes approval letter and other determination letters. |
| Draft or unapproved submissions | Includes drafts and submitted (but not approved) submissions, including submissions returned for changes. These will only be available in iRIS until it is retired in 2027. |
| Non-Human Subject Research (NHSR) determinations | These will only be available in iRIS until it is retired in 2027. |
| IRB meeting materials | Includes meeting agendas, minutes, and related materials. |
Migration Summary Table
| Type of Submission | Migrated to Research Gateway IRB | Accessible via iRIS or SharePoint (via link in Research Gateway IRB) | Accessible via iRIS Only (No Access After iRIS is Retired in 2027) |
|---|---|---|---|
| Approved IRB studies (see specific statuses above) | X (shell record) |
|
|
| Post-approval event reports (depends on outcome - see specific statuses above) | X (some) | X (some) |
|
| Exempt studies |
| X |
|
| Closed or withdrawn studies |
| X |
|
| Previously approved modifications and continuing reviews |
| X |
|
| Draft submissions or submitted, unapproved submissions |
|
| X |
| Non-Human Subject Research (NHSR) determinations |
|
| X |
| Approved GESCR studies | X (shell record) |
|
|
| Document Type | Research Gateway IRB | Accessible via iRIS or SharePoint (via link in Research Gateway IRB) |
|---|---|---|
| Currently approved/acknowledged study documents | X |
|
| Currently approved stamped consent form and editable version of the approved consent form | X |
|
| Historical consent forms and other study documents |
| X |
| Approval letters and other outcome letters |
| X |
| IRB meeting materials (e.g., minutes, agendas) |
| X |
OnCore Integration
For detailed OnCore workflow and system changes, see the Office of Clinical Trial Administration (OCTA) guidance at OnCore Changes with Research Gateway IRB - 2026.
Frequently Asked Questions
This FAQ provides guidance on what to expect, including system integrations, workflow changes, and the management of existing studies. This is a living document that will be updated as new information becomes available. For specific questions raised during the March 25th Town Hall, please refer to our separate supplemental Q&A document.
System Transition
Submissions & Workflow
System Integration
Contact
If you have questions about this transition, please contact:
Research Gateway Project Team at [email protected].
Information Sessions
| Sessions | Date/Time | Invite/Materials |
|---|---|---|
| Past | ||
| Research Gateway Town Hall: IRB System Replacement | Wed, March 25, 11:00–12:00 | If you work at an UCSF Affiliated Institution, you can request access to these materials by emailing Kate Nolan. |
| Clinical Trials Operations (CTO) Research Forum | Thurs, April 9, 11:00–12:00 | |
Previous Communications
Earlier communications about this transition include:
| Office | Communication |
|---|---|
| Academic Research Services (ARS) |
|
| Office of Research (OoR) |
|
| Clinical Trials Operations (CTO) |
|